Mira Pharmaceuticals risks Nasdaq delisting after shares fall below $1 bid price requirement

MIRA•2026-07-31

Nasdaq bid-price notice and compliance deadline

Mira Pharmaceuticals received a Nasdaq notice for failing to meet the $1 minimum bid price rule after 30 straight business days below $1.

Shares remain listed on the Nasdaq Capital Market under MIRA with no immediate impact on trading.

The compliance deadline is set for Jan. 25, 2027. The stock must close at or above $1 for 10 consecutive business days to regain compliance.

If Mira Pharmaceuticals fails to regain compliance, it could receive a delisting notice. A reverse stock split remains an option to cure the deficiency.

Sources

Mira Pharmaceuticals risks Nasdaq delisting after shares fall below $1 bid price requirement

Sec

Mira Pharmaceuticals risks Nasdaq delisting after shares fall below $1 bid price requirement

Nasdaq bid-price notice and compliance deadline

Related News

CaliberCos updates financial calendar with Q2 earnings release and investor call

Core AI Holdings Announces Receipt Of Nasdaq Notification Regarding Minimum Bid Price Compliance Deficiency

aTyr Pharma - Co And Kyorin Terminate Collaboration Agreement Effective July 30, 2026

Sources

Mira Pharmaceuticals risks Nasdaq delisting after shares fall below $1 bid price requirement

CDT Equity issues pre-funded warrants for 12,131,770 shares in Sarborg stake deal

Exxon, Chevron warn of continued high fuel prices from Iran war